While no definitive evidence indicates that tumor-derived iNOS is catalytically inactive, the possibility exists that tumor cells have evolved adaptive mechanisms to buffer or exploit high-output NO synthesis for tumor-promoting processes. This evidence concerns the gene NOS2 and neoplasm.